logo
Sign in

EUCRU Stock Price, Chart, Stats & News

Eucrates Biomedical Acquisition Corp.
Save
47.26M
Market cap
42.82x
Current P/E
Forward P/E

EUCRU chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
Operating margin
Pretax margin
Net margin
Effective tax rate
-128.84%
ROA
44.36%
ROE
10.27%
D/E
0.01x
Interest coverage ratio

EUCRU valuation

P/E
42.82x
P/S
P/B
3.50x
P/CF
-47.45x
P/FCF
-67.00x
P/OCF
-47.45x
PEG
0.05x
EV multiple
-16.38x

About

Eucrates Biomedical Acquisition Corp. currently possesses no substantial business activities. Its primary objective is to execute a business combination, which may involve a merger, an acquisition of shares or assets, or a reorganization, with one or more enterprises. The firm specifically aims to identify and acquire a target company within the biomedical or healthcare sectors across North America and Europe.

Similar securities

Based on sector and market capitalization

Report issue